iCarbonX is a Chinese biotech startup that uses artificial intelligence to provide personalized health analyses and health index predictions. It has formed an alliance with several technology companies from around the world that specialize in gathering different types of healthcare data and will use algorithms to analyze genomic, physiological, and behavioral data. It also works to provide customized health and medical advice.
It has raised $289 million in funding so far, but it has not announced any plans to go public. However, some of its competitors, such as Cohesity and Via, have filed for IPOs recently.